Programmed death-1(PD-1) - Globe Thesis

Keyword [Programmed death-1(PD-1)] Result: 1 - 17 \| Page: 1 of 1
1.	The Associativity Between Programmed-death-1(PD-1) And The Progression Of Acute Hepatitis B
2.	Immunoregulatory Effects Of Sinomenine On The Inappropriate T-cell Immune Responses In The Treatment Of Mesangial Proliferative Nephritis
3.	Expression Level And Clinical Significance Of PD-1 And Tim-3 In Human Immunodeficiency Virus-1 Infected Individuals
4.	Expression And Clinical Significance Of PD-1 In CD8~+T Cell In Gastric Cancer Patients
5.	PD-1, CD4/CD8Ratio In Mycosis Fungoides, Eczema, Lichen Planus’s Expression Research
6.	Expression And Significance Of Programmed Death-1 And Programmed Death Ligand-1 In Cholesteatoma Otitis Media
7.	Overexpression Of Fibrinogen-like Protein 2 Downregulated The Expression Of Programmed Cell Death-1,Decreased Cardiac Function In Autoimmune Myocarditis Rats And The Molecular Mechanism Involved
8.	Expression And Clinical Significance Of PD-1 On The Peripheral CD8+ And CD4+ T Cell In Pancreatic Cancer Patients
9.	Expression And Significance Of Programmed Death-1(PD-1)and Its Ligand PD-L1 In Endometriosis
10.	Analysis Of Programmed Death 1(PD-1) And Its Ligands Expression In Epithelial Ovarian Cancer And Its Clinical Significance
11.	The Preliminary Study Of The Expression Of PD-1 And Tim-3 In Oral Lichen Planus
12.	Clinical Significance Of Programmed Death-1 And Programmed Death-ligand 1 Expression In Patients With Laryngeal And Hypopharyngeal Squamous Cell Carcinoma
13.	Expression And Significance Of PD-1 On CD4+and CD8+T Cells In Tumor Tissues And Adjacent Tissues Of NCSLC
14.	Expression And Mechanism Of PD-1/PD-L1 And Treg In JAK2 V617F-positive Myeloproliferative Neoplasms
15.	Correlation Between The Expression Of PD-1/PD-L1 On NK Cells And HBV Infection
16.	Expression Of The Human PD-1 Extracellular Domain And Its Nanobody Screening
17.	Clinical Analysis Of PD-1 Receptor Inhibitor Combined With P-Gemox-Dex Regimen In The Primary Treatment Of Phase ?/? Extranodal Natural Killer/T Cell Lymphoma
<<First <Prev Next> Last>> Jump to